KEY FEATURES

  • Regrettably 1 fatality

  • 30% improvement in TRIFR1 to 2.36%

    (December 2018: 3.39)

  • 2% decrease in ferrochrome production to 206kt

    (June 2018: 211kt)

  • 3% increase in revenue to R2 789 million

    (June 2018: R2 721 million)

  • 45% decrease in EBITDA to R435 million

    (June 2018: R796 million)

1 Total recordable injury frequency rate
2 Net cash includes cash and cash equivalents, bank overdraft and working capital loan
3 Earnings, before interest, tax, depreciation and amortisation

  • 61% decrease in HEPS and EPS3 6.6 cents

    (June 2018: 16.9 cents)

  • 124% increase in cashflow from operating activities to R197 million

    (June 2018: 88 million)

  • 27% decrease in net cash to R205 million2

    (December 2018: R281 million2)

  • No interim dividend declared

    (June 2018: R200 million)

1 Total recordable injury frequency rate
2 Net cash includes cash and cash equivalents, bank overdraft and working capital loan
3 Earnings, before interest, tax, depreciation and amortisation